This paper deals with the influence of the therapeutic context in batterer intervention programs. We conducted 2 complementary studies: a descriptive analysis (Study 1) and a qualitative study (Study 2) analyzing the aspects that may help to improve the operation and effectiveness of treatment in a group of men (N = 27) who participated in a program for convicted perpetrators of intimate partner violence. The results show a statistically significant relationship between the therapeutic alliance and the assessment of the usefulness of the program attended by offenders (r = .69, p < .01), and between the therapeutic alliance and the assessment of the usefulness of the program content (r = .43, p < .05). Furthermore, the results of the qualitative analysis show that aspects of the therapeutic context may play an important role for the adhesion of offenders to treatment, increasing their motivation and improving results. It is proposed that future research should provide more in-depth analysis of the elements related to the context of the intervention and therapists' skills as facilitators of change.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1017/sjp.2013.43 | DOI Listing |
Int Immunopharmacol
January 2025
West China School of Public Health and West China Fourth Hospital, Sichuan University, Chengdu, China. Electronic address:
Cervical cancer is the fourth most common cancer and the fourth leading cause of cancer death in women. Effective treatment of cervical cancer is urgently needed. Tumor therapeutic vaccine is a research hotspot in tumor immunotherapy, and the tumor therapeutic vaccine based on attenuated live bacteria carrier has clinical application prospect because of its clear action site and high safety.
View Article and Find Full Text PDFJMIR Ment Health
January 2025
Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT, United States.
Background: Evidence-based digital therapeutics represent a new treatment modality in mental health, potentially providing cost-efficient, accessible means of augmenting existing treatments for chronic mental illnesses. CT-155/BI 3972080 is a prescription digital therapeutic under development as an adjunct to standard of care treatments for patients 18 years of age and older with experiential negative symptoms (ENS) of schizophrenia. Individual components of CT-155/BI 3972080 are designed based on the underlying principles of face-to-face treatment.
View Article and Find Full Text PDFPain
January 2025
Innovation, IMPlementation And Clinical Translation (IIMPACT) in Health, University of South Australia, Kaurna Country, Adelaide, Australia.
Physiotherapists are critically positioned to integrate education into patient care, including pain science education (PSE) to enhance management and outcomes. Anecdotally, many physiotherapists report difficulty providing PSE in private practice settings. Here, we aimed to explore current PSE use, knowledge, and barriers to implementation.
View Article and Find Full Text PDFBJPsych Open
January 2025
ICOnnecta't Digital Health Program, Catalan Institute of Oncology, Hospitalet del Llobregat, Spain; Psychooncology and Digital Health Group, The Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet del Llobregat, Spain; and Department of Clinical Psychology and Psychobiology, Universitat de Barcelona, Spain.
Background: Action mechanisms of therapeutic alliance in stepped and digital interventions remain unclear.
Aims: (a) To compare the development of therapeutic alliance between psychosocial treatment as usual (PTAU) and a stepped digital intervention designed to prevent distress in cancer patients; (b) to analyse the level of agreement between patients' and therapists' therapeutic alliance ratings; and (c) to explore variables associated with therapeutic alliance in the digital intervention.
Method: A multicentre randomised controlled trial with 184 newly diagnosed breast cancer women was conducted.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!